Key Metrics of Edwards Lifesciences
Revenue$5.0B▲ 12.2% YoYFY 2023
Operating income$1.3B▼ 12.6% YoY
Net profit$1.4B▼ 7.9% YoY
Shareholders' equity$6.7B
Market cap$53.0BEW · $92.01
Competitors10identified
About Edwards Lifesciences
Part of Edwards Lifesciences.
Sectors
Company details
- Website
- EdwardsLifesciences.com
- Listed
- NYSE: EW
Operational Areas of Edwards Lifesciences
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Pharmaceuticals & Healthcare›Medical Devices & Diagnostics
Company summary
Legal nameEdwards Lifesciences Corporation
TickerEW
ExchangeNYSE
CountryUnited States
SEC CIK0001099800
Listed since—
IndustryIndustrial Specialties
SectorPharmaceuticals & Healthcare · Medical Devices & Diagnostics
Websitehttp://www.EdwardsLifesciences.com
US market & SEC filings
EW · NYSE · SEC CIK 0001099800
Last price · 02 Nov 2026
$92.01
−2.57%
Market cap$53.0B
P/E40.0On FY 2023 diluted EPS
Volume6,044,702
SectorHealth CareIndustrial Specialties
Country · IPOUnited States
EW share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeNoviodunum
GSTIN—
Email—
Websitehttp://www.EdwardsLifesciences.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Edwards Lifesciences
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Part of Edwards Lifesciences
Business activities and related parties
medical device
Filings
No filings on record yet.